The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 274.00
Bid: 270.50
Ask: 271.50
Change: 13.00 (4.98%)
Spread: 1.00 (0.37%)
Open: 256.50
High: 274.00
Low: 256.50
Prev. Close: 261.00
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 2019 Pre-Close Trading Update

25 Sep 2018 07:00

RNS Number : 7838B
CMC Markets Plc
25 September 2018
 

25 September 2018

 

 

CMC Markets Plc

 

H1 2019 Pre-Close Trading Update

 

 

CMC Markets Plc (LSE:CMCX, "CMC" or "the Group"), a leading global provider of online trading, today issues a trading update covering the period from 1 July 2018 to 25 September 2018 ("the Period").

 

After a solid first quarter, the second quarter has been impacted by a sustained period of low market volatility and range bound markets towards the end of the traditional UK summer period, in addition to an expected decrease in overall client trading activity following regulatory change. As a result, net operating income for 2019 is expected to be below previous guidance, with the overall impact on profitability partially mitigated by tight cost control. Following the summer period, the Group has seen some improvement in client activity levels.

 

The implementation of the ESMA measures has reduced UK and European retail client activity as expected. However, after just two months it remains too early to draw any real conclusions as to how clients will adapt to the new rules. Taken alongside the aforementioned reduction in market volatility and range bound markets during a period of the second quarter, CFD and spread bet revenue for the full year is now expected to see a c. 20% reduction year-on-year, below previous guidance for a 10% to 15% reduction year-on-year.

 

The Group continues to deliver on its strategy, having successfully completed the implementation of the white label stockbroking partnership with ANZ Bank in Australia as expected in the last week of the Period, which is expected to drive growth and further diversify revenues. In July, 103 intermediaries were migrated to CMC's Stockbroking platform and, in September, ANZ Bank's retail stockbroking clients were successfully migrated. In addition, to meet client demand, MT4, the foreign exchange platform, will be launched in Q3 2019.

 

The Group also maintains a strong focus on operating costs. Investments in strategic initiatives to drive future growth are ongoing, however discretionary spend around staff and marketing costs is now expected to be lower than previous guidance. As a result, 2019 operating costs are now expected to be just slightly higher year-on-year, partially mitigating the overall impact of Q2 2019 revenue performance on Group profitability for the full year.

 

Throughout the Period, the Group remained focussed on increasing the proportion of UK and European revenue generated by professional clients (where the criteria are met). On a rolling 12-month view over 40% of UK and European revenue is now generated by professional clients, in line with previous guidance. Including institutional business this increases to 50%.

 

H1 2019 Results

The results for the six months ending 30 September 2018 will be announced on 22 November 2018.

 

There will be a presentation on 22 November 2018 at 9.30am for institutional investors and analysts at CMC's offices at 133 Houndsditch, London, EC3A 7BX, United Kingdom. Those wishing to attend should contact investor.relations@cmcmarkets.com.

 

Forward looking statements

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward looking statements to reflect events or developments occurring after the date such statements are published.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR"). Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is considered to be in the public domain.

 

Enquiries

CMC Markets Plc +44 (0) 20 7170 8200

Grant Foley, Chief Operating and Financial Officer

 

Camarco +44 (0) 20 3757 4980

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

Notes to Editors

CMC Markets plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 14 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDMGZLGDRGRZZ
Date   Source Headline
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSCOVID-19 and Trading Update
12th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20202:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSTrading Update
7th Feb 202010:56 amRNSDirector/PDMR Shareholding
23rd Jan 20207:00 amRNSQ3 Trading Update
8th Jan 20203:20 pmRNSDirector/PDMR Shareholding
9th Dec 20192:29 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSInterim Results
7th Nov 20193:54 pmRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSBoard Changes
15th Oct 201912:02 pmRNSPrice Monitoring Extension
9th Oct 20193:54 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSH1 2020 Pre-Close Trading Update
17th Sep 20193:36 pmRNSDirector/PDMR Shareholding
17th Sep 20193:22 pmRNSIssue of Equity
13th Sep 20194:27 pmRNSDirector/PDMR Shareholding
9th Sep 20193:06 pmRNSDirector Declaration
30th Aug 201912:02 pmRNSNotification of transaction by PDMR's PCA
30th Aug 201911:49 amRNSDirector/PDMR Shareholding
22nd Aug 201911:52 amRNSResponse to ASIC consultation paper
9th Aug 201912:25 pmRNSHolding(s) in Company
6th Aug 20194:19 pmRNSDirector/PDMR Shareholding
25th Jul 20193:19 pmRNSResult of AGM
25th Jul 20197:00 amRNSQ1 Trading Update
15th Jul 20192:28 pmRNSHolding(s) in Company
9th Jul 201912:41 pmRNSDirector/PDMR Shareholding
28th Jun 201911:50 amRNSNotice of AGM
24th Jun 20192:26 pmRNSHolding(s) in Company
7th Jun 201912:06 pmRNSDirector/PDMR Shareholding
6th Jun 20197:01 amRNSDirector Change
6th Jun 20197:00 amRNSFinal Results
23rd May 20194:13 pmRNSHolding(s) in Company
9th May 20194:05 pmRNSDirector/PDMR Shareholding
3rd Apr 20197:01 amRNSDirector Changes
3rd Apr 20197:00 amRNSTrading Update
2nd Apr 20199:04 amRNSDirector Declaration
7th Mar 20194:05 pmRNSDirector/PDMR Shareholding
22nd Feb 20192:21 pmRNSTrading Update
22nd Feb 201912:00 pmRNSHolding(s) in Company
8th Feb 201911:35 amRNSIssue of Equity
7th Feb 20192:59 pmRNSDirector/PDMR Shareholding
24th Jan 20197:00 amRNSQ3 2019 Trading Update
9th Jan 20199:53 amRNSDirector/PDMR Shareholding
27th Dec 20181:45 pmRNSDirector/PDMR Shareholding
17th Dec 20182:45 pmRNSHolding(s) in Company
10th Dec 20185:29 pmRNSHolding(s) in Company
7th Dec 20189:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.